NUCLEAR THERAPEUTICS HUB
Targeted Radiotherapies
Radionuclide Therapy
Explore the science and clinical application of targeted radionuclide therapies in modern oncology. Discover how radiopharmaceutical innovation enables personalised molecular treatment strategies.
Radiopharmaceuticals
Learn how radiolabelling, isotope selection and molecular targeting underpin effective nuclear therapeutics. Understand the translational pathway from laboratory development to regulated clinical delivery.
Precision Oncology
Contribute to advancing safe, research-informed nuclear therapeutics through collaboration and shared expertise. Support innovation that strengthens personalised treatment and improves patient outcomes.
Radiolabelling
Radiolabelling incorporates radioactive isotopes into molecules to trace biological processes and molecular pathways. This technique is used in drug development, metabolic research and translational nuclear medicine.
Radiotherapeutics
Radiotherapeutics uses targeted radionuclides such as actinium-225 to deliver cytotoxic radiation to malignant cells. This approach concentrates dose within tumours while limiting exposure to surrounding tissue.
Clinical Technologist
Clinical technologists prepare radiopharmaceuticals and operate nuclear medicine systems within regulated environments. They ensure protocol adherence, radiation safety and accurate delivery of diagnostic and therapeutic procedures.
Radiopharmaceuticals
Radiopharmaceuticals combine biologically active molecules with radioactive isotopes for imaging and therapy. Their clinical application requires strict manufacturing controls, regulatory oversight and quality assurance.
Radiopharmacy
Radiopharmacy oversees formulation, preparation and dispensing of radiopharmaceuticals for clinical use. Also, it integrates safety procedures, sterility standards and compliance within nuclear medicine services.
Radiotheranostics
Radiotheranostics links diagnostic imaging with targeted radionuclide therapy using related molecular agents. This approach enables patient selection, treatment planning and response assessment within precision oncology.
EXPLORE
Targeted Treatment
Radiotherapeutics deliver cytotoxic radiation directly to malignant cells using specialised radionuclides. This targeted strategy maximises tumour control while limiting exposure to surrounding healthy tissues
Clinical technologists and radiopharmacists ensure the safe preparation, regulatory compliance, and accurate dosing of radiopharmaceuticals. The aim is to maintain sterility standards and ensure reliable therapeutic delivery.
CONTRIBUTE
Theranostic Integration
Radiotheranostics unites diagnostic imaging with targeted therapy using biologically matched molecular agents. This integrated approach supports patient selection, response monitoring and adaptive precision oncology.
Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer’s disease diagnosis and study.
Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases.
PET imaging is used in oncology, neurology and cardiology.
Discover how radiopharmaceuticals in medicine are transforming diagnostics and treatments with atomic precision for better health outcomes.
Uncover how PET/CT enhances thyroid cancer diagnosis. Explore its insights into tumours, staging, and personalised oncology.
EXPLORER, the world’s first medical imaging scanner to produce a 3-D picture of the whole human body.
home » nuclear therapeutics hub
